Diuretics

Jun 21, 2016 by in PHARMACY Comments Off on Diuretics

 regulation of plasma electrolyte concentrations and fluid balance,  regulation of acid–base balance,  elimination of waste products,  conservation of essential nutrients. Of these, a basic knowledge of the mechanisms of electrolyte…

read more

Nausea and vomiting

Jun 21, 2016 by in PHARMACY Comments Off on Nausea and vomiting

Fig. 32.1 Neuronal pathways and receptors involved in the control of nausea and vomiting.The pathways and neurotransmitter receptors involved in nausea and vomiting are complex and only those underpinning the…

read more

Skin disorders

Jun 21, 2016 by in PHARMACY Comments Off on Skin disorders

 ointments, which are greases such as white or yellow soft paraffin. They are more occlusive on the skin than creams, and this keeps the skin hydrated,  pastes, which are suspensions…

read more

Cerebrovascular disease and dementia

Jun 21, 2016 by in PHARMACY Comments Off on Cerebrovascular disease and dementia

 primary prevention of a first event (ischaemic or haemorrhagic stroke),  prevention of recurrence of stroke or of other cardiovascular events,  rehabilitation after the stroke. About one-third of strokes are recurrent….

read more

Anxiolytics, sedatives and hypnotics

Jun 21, 2016 by in PHARMACY Comments Off on Anxiolytics, sedatives and hypnotics

Fig. 20.1 The GABAA receptor.The GABAA receptor consists of five transmembrane subunits configured from the 19 possible subunits that have been identified; thus many configurations of the GABA receptor exist,…

read more

General anaesthetics

Jun 21, 2016 by in PHARMACY Comments Off on General anaesthetics

Drugs are used in combination to produce the appropriate balance of sedation, analgesia and muscle relaxation while minimising unwanted effects; at particular doses and concentrations, each contributes minor or major…

read more

Peripheral vascular disease

Jun 21, 2016 by in PHARMACY Comments Off on Peripheral vascular disease

 Diarrhoea.  Headache.  Palpitation and tachycardia.  Other PDE3 inhibitors such as milrinone have been shown to decrease survival in people with heart failure (Ch. 7); cilostazol does not appear to increase…

read more
Get Clinical Tree app for offline access